These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26144659)

  • 1. Expression and functionality of Toll- and RIG-like receptors in HepaRG cells.
    Luangsay S; Ait-Goughoulte M; Michelet M; Floriot O; Bonnin M; Gruffaz M; Rivoire M; Fletcher S; Javanbakht H; Lucifora J; Zoulim F; Durantel D
    J Hepatol; 2015 Nov; 63(5):1077-85. PubMed ID: 26144659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
    Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
    Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Transcriptome Analysis Shows That SAV-3 Infection Upregulates Pattern Recognition Receptors of the Endosomal Toll-Like and RIG-I-Like Receptor Signaling Pathways in Macrophage/Dendritic Like TO-Cells.
    Xu C; Evensen Ø; Munang'andu HM
    Viruses; 2016 Apr; 8(4):114. PubMed ID: 27110808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes.
    Ni Y; Urban S
    Methods Mol Biol; 2017; 1540():15-25. PubMed ID: 27975304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early inhibition of hepatocyte innate responses by hepatitis B virus.
    Luangsay S; Gruffaz M; Isorce N; Testoni B; Michelet M; Faure-Dupuy S; Maadadi S; Ait-Goughoulte M; Parent R; Rivoire M; Javanbakht H; Lucifora J; Durantel D; Zoulim F
    J Hepatol; 2015 Dec; 63(6):1314-22. PubMed ID: 26216533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
    Niu C; Li L; Daffis S; Lucifora J; Bonnin M; Maadadi S; Salas E; Chu R; Ramos H; Livingston CM; Beran RK; Garg AV; Balsitis S; Durantel D; Zoulim F; Delaney WE; Fletcher SP
    J Hepatol; 2018 May; 68(5):922-931. PubMed ID: 29247725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus.
    Schulze A; Mills K; Weiss TS; Urban S
    Hepatology; 2012 Feb; 55(2):373-83. PubMed ID: 21953491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toll-like receptor dependent innate immune responses by primary mouse hepatocytes and its control of HBV replication].
    Wu J; Chen MF; Xia YC; Guo Y; Lin Y; Sun C; Zhang CY; Chen Y; Liu SP; Hao YH; Lu MJ; Schlaak JF; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):838-42. PubMed ID: 22433306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma differentiation-associated gene 5 senses hepatitis B virus and activates innate immune signaling to suppress virus replication.
    Lu HL; Liao F
    J Immunol; 2013 Sep; 191(6):3264-76. PubMed ID: 23926323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype.
    Shen F; Li Y; Wang Y; Sozzi V; Revill PA; Liu J; Gao L; Yang G; Lu M; Sutter K; Dittmer U; Chen J; Yuan Z
    Hepatology; 2018 Apr; 67(4):1237-1252. PubMed ID: 29059468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.
    Lucifora J; Bonnin M; Aillot L; Fusil F; Maadadi S; Dimier L; Michelet M; Floriot O; Ollivier A; Rivoire M; Ait-Goughoulte M; Daffis S; Fletcher SP; Salvetti A; Cosset FL; Zoulim F; Durantel D
    Sci Rep; 2018 Mar; 8(1):5390. PubMed ID: 29599452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.
    Wang B; Trippler M; Pei R; Lu M; Broering R; Gerken G; Schlaak JF
    J Hepatol; 2009 Dec; 51(6):1037-45. PubMed ID: 19716616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells.
    Guo H; Jiang D; Ma D; Chang J; Dougherty AM; Cuconati A; Block TM; Guo JT
    J Virol; 2009 Jan; 83(2):847-58. PubMed ID: 18971270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of hepatitis B virus replication by innate response of HepaRG cells.
    Lucifora J; Durantel D; Testoni B; Hantz O; Levrero M; Zoulim F
    Hepatology; 2010 Jan; 51(1):63-72. PubMed ID: 19877170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIG-I-Like Receptor and Toll-Like Receptor Signaling Pathways Cause Aberrant Production of Inflammatory Cytokines/Chemokines in a Severe Fever with Thrombocytopenia Syndrome Virus Infection Mouse Model.
    Yamada S; Shimojima M; Narita R; Tsukamoto Y; Kato H; Saijo M; Fujita T
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.
    Das D; Sengupta I; Sarkar N; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakrabarti S; Chakravarty R
    BMC Infect Dis; 2017 Jan; 17(1):76. PubMed ID: 28088184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes.
    Desmares M; Delphin M; Chardès B; Pons C; Riedinger J; Michelet M; Rivoire M; Verrier B; Salvetti A; Lucifora J; Durantel D
    Antiviral Res; 2022 Oct; 206():105386. PubMed ID: 35963549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLRs antiviral effect on hepatitis B virus in HepG2 cells.
    Xia C; Lu M; Zhang Z; Meng Z; Zhang Z; Shi C
    J Appl Microbiol; 2008 Nov; 105(5):1720-7. PubMed ID: 19149768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.